ISSN:

Journal Home

Journal Guideline

Clinical Lymphoma, Myeloma and Leukemia Q3 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Lymphoma, Myeloma and Leukemia is a journal indexed in SJR in Hematology and Oncology with an H index of 65. It has a price of 2480 €. It has an SJR impact factor of 0,548 and it has a best quartile of Q3. It has an SJR impact factor of 0,548.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q3) Hematology (Q3) Oncology (Q3)

Price

2480 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,548

SJR Impact factor

65

H Index

160

Total Docs (Last Year)

1295

Total Docs (3 years)

6531

Total Refs

1737

Total Cites (3 years)

1261

Citable Docs (3 years)

1.13

Cites/Doc (2 years)

40.82

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Advances in Hematology Q3
Lymphology Q3
Hematology Q3
Journal of Blood Medicine Q3
Mediterranean Journal of Hematology and Infectious Diseases Q3

Compare this journals